Informações:
Falhas:
ID
26874
Descrição
Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00949598
Link
https://clinicaltrials.gov/show/NCT00949598
Palavras-chave
Versões (1)
- 27/10/2017 27/10/2017 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
27 de outubro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Breast Cancer NCT00949598
Eligibility Breast Cancer NCT00949598
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00949598
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Breast adenocarcinoma Invasive
Item
histologically confirmed invasive breast adenocarcinoma
boolean
C0858252 (UMLS CUI [1,1])
C0205281 (UMLS CUI [1,2])
C0205281 (UMLS CUI [1,2])
TNM Breast tumor staging Ultrasonography | Tumor size Ultrasonography
Item
clinically t2 tumor and/or > 1 cm by echography
boolean
C0474926 (UMLS CUI [1,1])
C0041618 (UMLS CUI [1,2])
C0475440 (UMLS CUI [2,1])
C0041618 (UMLS CUI [2,2])
C0041618 (UMLS CUI [1,2])
C0475440 (UMLS CUI [2,1])
C0041618 (UMLS CUI [2,2])
Estrogen receptor positive | Neoplastic Cell Positive Percentage
Item
estrogen receptor (er)-positive and > 10% of the tumor cells positive
boolean
C0279754 (UMLS CUI [1])
C0597032 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
C0597032 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
Exclusion | Disease Estrogen receptor negative
Item
no er-negative disease
boolean
C2828389 (UMLS CUI [1])
C0012634 (UMLS CUI [2,1])
C0279756 (UMLS CUI [2,2])
C0012634 (UMLS CUI [2,1])
C0279756 (UMLS CUI [2,2])
Exclusion | Breast Carcinoma Previous
Item
no prior breast cancer
boolean
C2828389 (UMLS CUI [1])
C0678222 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
C0678222 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
Exclusion Criteria | Breast adenocarcinoma metastatic | Breast adenocarcinoma inflammatory
Item
no metastatic or inflammatory breast adenocarcinoma
boolean
C0680251 (UMLS CUI [1])
C1697918 (UMLS CUI [2])
C0858252 (UMLS CUI [3,1])
C0333348 (UMLS CUI [3,2])
C1697918 (UMLS CUI [2])
C0858252 (UMLS CUI [3,1])
C0333348 (UMLS CUI [3,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Postmenopausal state
Item
postmenopausal
boolean
C0232970 (UMLS CUI [1])
Exclusion Criteria | Cardiac function Contraindicated Operative Surgical Procedures | Cardiac function Contraindicated Therapeutic procedure | Therapeutic radiology procedure | Chemotherapy
Item
no cardiac function that could contraindicate surgery or medical treatment (e.g., radiotherapy and/or chemotherapy)
boolean
C0680251 (UMLS CUI [1])
C0232164 (UMLS CUI [2,1])
C1444657 (UMLS CUI [2,2])
C0543467 (UMLS CUI [2,3])
C0232164 (UMLS CUI [3,1])
C1444657 (UMLS CUI [3,2])
C0087111 (UMLS CUI [3,3])
C1522449 (UMLS CUI [4])
C0392920 (UMLS CUI [5])
C0232164 (UMLS CUI [2,1])
C1444657 (UMLS CUI [2,2])
C0543467 (UMLS CUI [2,3])
C0232164 (UMLS CUI [3,1])
C1444657 (UMLS CUI [3,2])
C0087111 (UMLS CUI [3,3])
C1522449 (UMLS CUI [4])
C0392920 (UMLS CUI [5])
Exclusion | Malignant Neoplasms | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix
Item
no prior malignancies within the past 5 years except for nonmelanoma skin cancer or carcinoma in situ of the cervix
boolean
C2828389 (UMLS CUI [1])
C0006826 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0699893 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0851140 (UMLS CUI [4,2])
C0006826 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0699893 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0851140 (UMLS CUI [4,2])
Exclusion | Mental handicap Preventing Informed Consent
Item
no mental incapacitation that would preclude consent
boolean
C2828389 (UMLS CUI [1])
C1306341 (UMLS CUI [2,1])
C1292733 (UMLS CUI [2,2])
C0021430 (UMLS CUI [2,3])
C1306341 (UMLS CUI [2,1])
C1292733 (UMLS CUI [2,2])
C0021430 (UMLS CUI [2,3])
Exclusion Criteria | Medical contraindication Tamoxifen Citrate | Medical contraindication letrozole
Item
no contraindication to tamoxifen citrate or letrozole
boolean
C0680251 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C0079589 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0246421 (UMLS CUI [3,2])
C1301624 (UMLS CUI [2,1])
C0079589 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0246421 (UMLS CUI [3,2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Hormone replacement therapy | Therapeutic procedure Menopause | phytoestrogen therapy
Item
more than 8 days since prior hormone-replacement therapy or other treatment (i.e., phytoestrogen) for menopause
boolean
C0282402 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0025320 (UMLS CUI [2,2])
C1541283 (UMLS CUI [3])
C0087111 (UMLS CUI [2,1])
C0025320 (UMLS CUI [2,2])
C1541283 (UMLS CUI [3])
Exclusion | Therapeutic procedure Changing Estrogen Gene Expression Regulation
Item
no concurrent therapy that would modify the expression of the genes regulated by estrogen
boolean
C2828389 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C0014939 (UMLS CUI [2,3])
C0017263 (UMLS CUI [2,4])
C0087111 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C0014939 (UMLS CUI [2,3])
C0017263 (UMLS CUI [2,4])
Study Subject Participation Status | Exclusion
Item
no concurrent participation in another clinical study
boolean
C2348568 (UMLS CUI [1])
C2828389 (UMLS CUI [2])
C2828389 (UMLS CUI [2])